SEC 13F Intelligence

Epoch Investment Partners, Inc. / REGN

Epoch Investment Partners, Inc.’s Regeneron Pharmaceuticals Position

Does Epoch Investment Partners, Inc. own Regeneron Pharmaceuticals (REGN)? Yes — 238.7K shares worth $184M (+1.12% of its 13F portfolio) as of Q1 2026, down from 281.3K shares the prior filed quarter.

Position Value
$184M
Q1 2026
Shares
238.7K
% of Portfolio
+1.12%
Quarters Held
9
currently held

Position History REGN

Reported value by quarter
Q1 ’24: $100MQ1 ’24Q2 ’24: $172MQ3 ’24: $166MQ3 ’24Q4 ’24: $141MQ1 ’25: $132MQ1 ’25Q2 ’25: $107MQ3 ’25: $146MQ3 ’25Q4 ’25: $217MQ1 ’26: $184MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026238.7K$184M+1.12%
Q4 2025281.3K$217M+1.23%
Q3 2025259.2K$146M+0.80%
Q2 2025203.1K$107M+0.55%
Q1 2025207.5K$132M+0.68%
Q4 2024197.3K$141M+0.68%
Q3 2024157.7K$166M+0.74%
Q2 2024163.3K$172M+0.78%
Q1 2024103.6K$100M+0.44%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Epoch Investment Partners, Inc.’s full portfolio or all institutional holders of REGN.